The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use

机译：西他列汀处方限制计划对糖尿病药物使用的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundHealth plans have responded to the many treatment options for type 2 diabetes mellitus by implementing formulary restriction policies, including step therapy, to control costs. Little is known about the impact of step therapy programs on antidiabetes medication use.

机译：BackgroundHealth计划通过实施包括限制疗法在内的处方限制政策来控制成本，从而对2型糖尿病的许多治疗选择做出了回应。关于逐步治疗计划对抗糖尿病药物使用的影响知之甚少。

著录项

期刊名称 American Health Drug Benefits
作者
Yuexin Tang; Xingyue Huang; Jinan Liu; R. Ravi Shankar; Michael L. Ganz; Swapnil Rajpathak; Quang T. Nguyen;
展开▼
作者单位

展开▼
年(卷),期 2017(10),9
年度 2017
页码 456–462
总页数 7
原文格式 PDF
正文语种
中图分类药学;
关键词
diabetes mellitus dipeptidyl peptidase-4 inhibitors drug utilization formulary restriction program managed care programs multitier formulary sitagliptin step therapy;

机译：糖尿病;二肽基肽酶-4抑制剂;药物利用;处方限制计划;管理式护理计划;多层处方;西他列汀;阶梯疗法;

相似文献

外文文献
中文文献
专利

1. Impact of Formulary Restrictions on Medication Intensification in Diabetes Treatment [J] . Stuart Bruce C., Slejko Julia F., Rueda Juan-David, The American journal of managed care . 2018,第5期

机译：式限制对糖尿病治疗中药物强化的影响
2. Description of anti-diabetic drug utilization pre- and post-formulary restriction of sitagliptin: findings from a national health plan [J] . Huang Xingyue, Liu Zhiwen, Shankar Ravi R., Current medical research and opinion . 2015,第8期

机译：西他列汀处方前和处方后限制使用抗糖尿病药物的描述：一项国家卫生计划的发现
3. Aligning Formulary Restrictions Across a Health System and Improving Access to and Clarity of Medication Restrictions [J] . Sarah Solano, Jordan Dow, Terry Audley, P & T: a peer-reviewed journal for formulary management . 2019,第2期

机译：对齐卫生系统的正义限制，提高药物限制的访问和清晰度
4. The role of external memory in a complex task: Effects of device and memory restrictions on program generation [C] . Simon P. Davies International conference on human-computer interaction . 1999

机译：外部内存在复杂任务中的作用：设备和内存限制对程序生成的影响
5. Effects of a formulary expansion on the use of atypical antipsychotics and health care services by patients with schizophrenia in the California Medicaid Program. [D] . Mulani, Parvez. 2009

机译：在加利福尼亚医疗补助计划中，处方药扩展对精神分裂症患者使用非典型抗精神病药和保健服务的影响。
6. Aligning Formulary Restrictions Across a Health System and Improving Access to and Clarity of Medication Restrictions [O] . Sarah Solano, Jordan Dow, Terry Audley, 2019

机译：调整整个卫生系统中的处方限制并改善药物限制的获取和明确性
7. Dissimilar Effects of Anagliptin and Sitagliptin on Lipoprotein Subclass in Standard or Strong Statin-Treated Patients with Type-2 Diabetes Mellitus: A Subanalysis of the REASON (Randomized Evaluation of Anagliptin versus Sitagliptin on Low-Density LipoproteiN Cholesterol in Diabetes) Trial [O] . Hiroyuki Hirai, Moritake Higa, Takeshi Morimoto, 2019

机译：Anagliptin和SitaGlittin对2型糖尿病患者脂蛋白亚类脂蛋白亚类的不同影响MELLITUS的患者：对糖尿病患者的低密度脂蛋白胆固醇对SINAGLIPTIN的随机评估）试验
8. Programmable Implantable Medication System: Its Application to Diabetes. Final Report October 1979-December 1985 [R] . Saudek, C. D. 1985

机译：可编程植入式药物治疗系统：其在糖尿病中的应用。 1979年10月至1985年12月的最终报告

The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use

摘要

著录项

相似文献

相关主题

期刊订阅